Dr. Frederick Ogwara, MD
Pediatrics (Pediatrics Physician)
3244 Meridiana Pkwy Ste 600
Rosharon, TX 77583
Who else practices at this address →
Brazoria County includes primary care (52% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2011
Licensed in Texas since 2020, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
TX license S7520 (first issued 2020; active) · MI license 4301104652 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 4 companies reported 16 payments worth $229 in total to this clinician.
| Collegium Pharmaceutical, Inc. | $152 |
|---|---|
| Ars Pharmaceuticals Operations, Inc. | $37.13 |
| Kyowa Kirin, Inc. | $21.87 |
| Merck Sharp & Dohme LLC | $18.06 |
| Food and Beverage | $229 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $32,000 in research payments for these studies, mostly to the institutions running them.
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Sanofi Pasteur Inc. · Active, not recruiting · NCT06736041
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.